Stepwise radical endoscopic resection for Barrett’s esophagus with early neoplasia: report on a Brussels’ cohort

Background and study aims: The aim of this retrospective study was to assess safety and efficacy of stepwise radical endoscopic resection (SRER) in patients with Barrett’s esophagus with high-grade intraepithelial neoplasia (HGIN) or early cancer.

Patients and methods: Patients undergoing SRER between 2000 and 2006 were retrospectively evaluated. Patients with Barrett’s esophagus who also had HGIN or early cancer were included if they had no signs of submucosal infiltration or metastases. SRER was performed using the cap-technique, at 8-week intervals until all Barrett’s esophagus was removed. Follow-up endoscopy was scheduled every 6 months.

Results: A total of 34 patients were included (31 male, mean 67 years, median Barrett’s dimensions C1M4). HGIN / early cancer was eradicated in all patients in a median of two endoscopic resection sessions (IQR 1–2 sessions). Twelve patients underwent additional argon plasma coagulation for small islets or an irregular Z-line. Barrett’s esophagus was eradicated in 28 patients (82 %). Complications occurred in 3/34 patients (9 %): two perforations, one delayed bleeding. In all, 19 patients (56 %) developed dysphagia, which was resolved with dilatation or stent placement. During a median follow-up period of 23 months (IQR 15 – 41 months), HGIN / early cancer recurred in three patients (9 %): two were retreated with endoscopic resection and one patient was referred for curative surgery. Five patients (15 %) had recurrence of nondysplastic Barrett’s esophagus. At the end of the follow-up period all patients were free of HGIN / early cancer (one patient after surgery), and 23 patients (68 %) had complete endoscopic and histological eradication of Barrett’s esophagus.

Conclusions: SRER resulted in complete eradication of HGIN/early cancer in all patients, and eradication of Barrett’s esophagus in a majority of cases. A significant number of patients develop dysphagia, which can be successfully treated endoscopically.

References

• 1 Holmes R S, Vaughan T L. Epidemiology and pathogenesis of esophageal cancer.  Semin Radiat Oncol. 2007;  17 2-9
• 2 Drewitz D J, Sampliner R E, Garewal H S. et al . The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years.  Am J Gastroenterol. 1997;  92 212-215
• 3 Hameeteman W, Tytgat G N, Houthoff H J. et al . Barrett’s esophagus: development of dysplasia and adenocarcinoma.  Gastroenterology. 1989;  96 (5 Pt 1) 1249-1256
• 4 Buttar N S, Wang K K, Lutzke L S. et al . Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus.  Gastrointest Endosc. 2001;  54 682-688
• 5 Peters F P, Kara M A, Rosmolen W D. et al . Endoscopic treatment of high grade dysplasia and early cancer in Barrett’s esophagus.  Gastrointest Endosc. 2005;  61 506-514
• 6 Ell C, May A, Pech O. et al . Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer).  Gastrointest Endosc. 2007;  65 3-10
• 7 Deprez P H, Aouattah T, Piessevaux H. Endoscopic removal or ablation of oesophageal and gastric superficial tumours.  Acta Gastroenterol Belg. 2006;  69 304-311
• 8 May A, Gossner L, Pech O. et al . Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach.  Eur J Gastroenterol Hepatol. 2002;  14 1085-1091
• 9 Peters F P, Kara M A, Rosmolen W D. et al . Poor results of 5-ALA-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett’s esophagus after endoscopic resection.  Endoscopy. 2005;  37 418-424
• 10 Gossner L, Stolte M, Sroka R. et al . Photodynamic ablation of high-grade dysplasia and early cancer in Barrett’s esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
• 11 Ackroyd R, Kelty C J, Brown N J. et al . Eradication of dysplastic Barrett’s oesophagus using photodynamic therapy: long-term follow-up.  Endoscopy. 2003;  35 496-501
• 12 Overholt B F, Panjehpour M, Halberg D L. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results.  Gastrointest Endosc. 2003;  58 183-188
• 13 Pech O, Gossner L, May A. et al . Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett’s cancer and high-grade intraepithelial neoplasia.  Gastrointest Endosc. 2005;  62 24-30
• 14 Pereira-Lima J C, Busnello J V, Saul C. et al . High power setting argon plasma coagulation for the eradication of Barrett’s esophagus.  Am J Gastroenterol. 2001;  96 1662-1663
• 15 Spechler S J. Thermal ablation of Barrett’s esophagus: a heated debate.  Am J Gastroenterol. 2006;  101 1770-1772
• 16 Manner H, May A, Rabenstein T. et al . Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy.  Scand J Gastroenterol. 2007;  42 397-405
• 17 Krishnadath K K, Wang K K, Taniguchi K. et al . Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy.  Gastroenterology. 2000;  119 624-630
• 18 Garewal H, Ramsey L, Sharma P. et al . Biomarker studies in reversed Barrett’s esophagus.  Am J Gastroenterol. 1999;  94 2829-2833
• 19 Petersen B T, Chuttani R, Croffie J. et al . Photodynamic therapy for gastrointestinal disease.  Gastrointest Endosc. 2006;  63 927-932
• 20 Van Laethem J L, Peny M O, Salmon I. et al . Intramucosal adenocarcinoma arising under squamous re-epithelisation of Barrett’s esophagus.  Gut. 2000;  46 574-577
• 21 Van Hillegersberg R, Haringsma J, ten Kate F J. et al . Invasive adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus.  Dig Surg. 2003;  20 440-444
• 22 Inoue H, Endo M. Endoscopic esophageal mucosal resection using a transparent tube.  Surg Endosc. 1990;  4 198-291
• 23 Seewald S, Akaraviputh T, Seitz U. et al . Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma.  Gastrointest Endosc. 2003;  57 854-859
• 24 Giovannini M, Bories E, Pesenti C. et al . Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.  Endoscopy. 2004;  36 782-787
• 25 Peters F P, Kara M A, Rosmolen W D. et al . Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia. A prospective study.  Am J Gastro. 2006;  101 1449-1457
• 26 Soehendra N, Seewald S, Groth S. et al . Use of modified multiband ligator facilitates circumferential EMR in Barrett’s esophagus.  Gastrointest Endosc. 2006;  63 847-852
• 27 Lopes C V, Hela M, Pesenti C. et al . Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma.  Surg Endosc. 2007;  21 820-824
• 28 Larghi A, Lightdale C J, Ross A S. et al . Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.  Endoscopy. 2007;  39 1086-1091
• 29 Peters F P, Krishnadath K K, Rygiel A M. et al . Stepwise radical endoscopic resection of the complete Barrett’s esophagus with early neoplasia Tuccessfully eradicates pre-existing genetic abnormalities.  Am J Gastroenterol. 2007;  102 1853-1861
• 30 . The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.  Gastrointest Endosc. 2003;  58 (6 Suppl) S3-43